126 related articles for article (PubMed ID: 32097796)
1. Identification and biological evaluation of natural product Biochanin A.
Wang L; Li L; Han Q; Wang X; Zhao D; Liu J
Bioorg Chem; 2020 Apr; 97():103674. PubMed ID: 32097796
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, and biological evaluation of novel dual inhibitors targeting lysine specific demethylase 1 (LSD1) and histone deacetylases (HDAC) for treatment of gastric cancer.
Duan YC; Jin LF; Ren HM; Zhang SJ; Liu YJ; Xu YT; He ZH; Song Y; Yuan H; Chen SH; Guan YY
Eur J Med Chem; 2021 Aug; 220():113453. PubMed ID: 33957387
[TBL] [Abstract][Full Text] [Related]
3. Triazole-dithiocarbamate based selective lysine specific demethylase 1 (LSD1) inactivators inhibit gastric cancer cell growth, invasion, and migration.
Zheng YC; Duan YC; Ma JL; Xu RM; Zi X; Lv WL; Wang MM; Ye XW; Zhu S; Mobley D; Zhu YY; Wang JW; Li JF; Wang ZR; Zhao W; Liu HM
J Med Chem; 2013 Nov; 56(21):8543-60. PubMed ID: 24131029
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and biological evaluation of tetrahydroquinoline-based reversible LSD1 inhibitors.
Wang X; Zhang C; Zhang X; Yan J; Wang J; Jiang Q; Zhao L; Zhao D; Cheng M
Eur J Med Chem; 2020 May; 194():112243. PubMed ID: 32229389
[TBL] [Abstract][Full Text] [Related]
5. Discovery of novel tranylcypromine-based derivatives as LSD1 inhibitors for gastric cancer treatment.
Ma QS; Zhang YF; Li CY; Zhang WX; Yuan L; Niu JB; Song J; Zhang SY; Liu HM
Eur J Med Chem; 2023 May; 251():115228. PubMed ID: 36881982
[TBL] [Abstract][Full Text] [Related]
6. 6-Heterocyclic carboxylic ester derivatives of gliotoxin lead to LSD1 inhibitors in gastric cancer cells.
Shan L; Li Z; Chen H; Ge M; Sun Y; Sun Y; Li Y; Li H; Fu L; Liu H
Bioorg Chem; 2023 Feb; 131():106150. PubMed ID: 36508940
[TBL] [Abstract][Full Text] [Related]
7. Identifying the novel inhibitors of lysine-specific demethylase 1 (LSD1) combining pharmacophore-based and structure-based virtual screening.
Sun XD; Zheng YC; Ma CY; Yang J; Gao QB; Yan Y; Wang ZZ; Li W; Zhao W; Liu HM; Ding L
J Biomol Struct Dyn; 2019 Oct; 37(16):4200-4214. PubMed ID: 30366512
[TBL] [Abstract][Full Text] [Related]
8. Arborinine, a potential LSD1 inhibitor, inhibits epithelial-mesenchymal transition of SGC-7901 cells and adriamycin-resistant gastric cancer SGC-7901/ADR cells.
Chu Y; Xiao Z; Jing N; Yan W; Wang S; Ma B; Zhang J; Li Y
Invest New Drugs; 2021 Jun; 39(3):627-635. PubMed ID: 33215324
[TBL] [Abstract][Full Text] [Related]
9. LPE-1, an orally active pyrimidine derivative, inhibits growth and mobility of human esophageal cancers by targeting LSD1.
Wang B; Zhao B; Pang LP; Zhao YD; Guo Q; Wang JW; Zheng YC; Zhang XH; Liu Y; Liu GY; Guo WG; Wang C; Li ZH; Mao XJ; Yu B; Ma LY; Liu HM
Pharmacol Res; 2017 Aug; 122():66-77. PubMed ID: 28571892
[TBL] [Abstract][Full Text] [Related]
10. Biochanin A reduces pancreatic cancer survival and progression.
Bhardwaj V; Tadinada SM; Jain A; Sehdev V; Daniels CK; Lai JC; Bhushan A
Anticancer Drugs; 2014 Mar; 25(3):296-302. PubMed ID: 24201306
[TBL] [Abstract][Full Text] [Related]
11. Discovery of higenamine as a potent, selective and cellular active natural LSD1 inhibitor for MLL-rearranged leukemia therapy.
Fang Y; Yang C; Teng D; Su S; Luo X; Liu Z; Liao G
Bioorg Chem; 2021 Apr; 109():104723. PubMed ID: 33618250
[TBL] [Abstract][Full Text] [Related]
12. Biochanin-A induces apoptosis and suppresses migration in FaDu human pharynx squamous carcinoma cells.
Cho IA; You SJ; Kang KR; Kim SG; Oh JS; You JS; Lee GJ; Seo YS; Kim DK; Kim CS; Lee SY; Kim JS
Oncol Rep; 2017 Nov; 38(5):2985-2992. PubMed ID: 28901495
[TBL] [Abstract][Full Text] [Related]
13. Discovery of tranylcypromine analogs with an acylhydrazone substituent as LSD1 inactivators: Design, synthesis and their biological evaluation.
Sun K; Peng JD; Suo FZ; Zhang T; Fu YD; Zheng YC; Liu HM
Bioorg Med Chem Lett; 2017 Nov; 27(22):5036-5039. PubMed ID: 29037950
[TBL] [Abstract][Full Text] [Related]
14. Flavone-based natural product agents as new lysine-specific demethylase 1 inhibitors exhibiting cytotoxicity against breast cancer cells in vitro.
Xu X; Peng W; Liu C; Li S; Lei J; Wang Z; Kong L; Han C
Bioorg Med Chem; 2019 Jan; 27(2):370-374. PubMed ID: 30552007
[TBL] [Abstract][Full Text] [Related]
15. Bioactivity evaluation of natural product α-mangostin as a novel xanthone-based lysine-specific demethylase 1 inhibitor to against tumor metastasis.
Han C; Li Z; Hou J; Wang Z; Xu D; Xue G; Kong L
Bioorg Chem; 2018 Feb; 76():415-419. PubMed ID: 29274582
[TBL] [Abstract][Full Text] [Related]
16. Design and synthesis of isatin/triazole conjugates that induce apoptosis and inhibit migration of MGC-803 cells.
Yu B; Wang SQ; Qi PP; Yang DX; Tang K; Liu HM
Eur J Med Chem; 2016 Nov; 124():350-360. PubMed ID: 27597411
[TBL] [Abstract][Full Text] [Related]
17. Interference of lysine-specific demethylase 1 inhibits cellular invasion and proliferation in vivo in gastric cancer MKN-28 cells.
Li Y; Tian X; Sui CG; Jiang YH; Liu YP; Meng FD
Biomed Pharmacother; 2016 Aug; 82():498-508. PubMed ID: 27470390
[TBL] [Abstract][Full Text] [Related]
18. The effect of biochanin A on cell growth, apoptosis, and migration in osteosarcoma cells.
Zhao Y; Wang L; Zhai X; Cui T; Wang G; Pang Q
Pharmazie; 2018 Jun; 73(6):335-341. PubMed ID: 29880086
[TBL] [Abstract][Full Text] [Related]
19. Lysine-specific demethylase 1 activation by vitamin B2 attenuates efficacy of apatinib for proliferation and migration of gastric cancer cell MGC-803.
Ma JL; Zhang T; Suo FZ; Chang J; Wan XB; Feng XJ; Zheng YC; Liu HM
J Cell Biochem; 2018 Jun; 119(6):4957-4966. PubMed ID: 29384217
[TBL] [Abstract][Full Text] [Related]
20. Baicalin, a natural LSD1 inhibitor.
Zheng YC; Shen DD; Ren M; Liu XQ; Wang ZR; Liu Y; Zhang QN; Zhao LJ; Zhao LJ; Ma JL; Yu B; Liu HM
Bioorg Chem; 2016 Dec; 69():129-131. PubMed ID: 27814566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
